Free Trial

Summit Therapeutics (SUMM) News Today

Summit Therapeutics logo
Serina Therapeutics to Present at LNP Summit
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
IRLAB to Present at BioStock Life Science Summit 2024
Stifel Nicolaus Keeps Their Buy Rating on Relay Therapeutics (RLAY)
Summit Therapeutics initiated with an Outperform at JMP Securities
Summit Therapeutics Advances NSCLC Trials and Strengthens Financials
MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit
Stifel Nicolaus Keeps Their Buy Rating on Summit Therapeutics (SMMT)
SERINA THERAPEUTICS INC. (2BO.BE)
Get Summit Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUMM and its competitors with MarketBeat's FREE daily newsletter.

2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)

Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.

Click here to see Dan's full warning to the public.

SUMM Media Mentions By Week

SUMM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SUMM
News Sentiment

1.11

0.60

Average
Medical
News Sentiment

SUMM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SUMM Articles
This Week

0

2

SUMM Articles
Average Week

Get Summit Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUMM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (LON:SUMM) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners